| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.28B | +1.7% |
| Cost of Revenue | $2.88B | +1.7% |
| Gross Profit | $7.40B | +1.7% |
| R&D Expense | $1.48B | -4.2% |
| SG&A Expense | $914.0M | -23.6% |
| Operating Income | $2.32B | +19.4% |
| Pre-tax Income | $2.28B | -38.5% |
| Income Tax | $297.0M | -68.1% |
| Net Income | $1.98B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.43B | +22.6% |
| Accounts Receivable | $108.0M | +14.9% |
| Current Assets | $7.57B | -31.3% |
| Total Assets | $19.36B | -10.4% |
| Current Liabilities | $6.10B | +34.9% |
| Long-term Debt | $5.75B | -17.5% |
| Total Liabilities | $14.21B | -6.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.41B | -0.5% |
| Capital Expenditures | $458.0M | +0.4% |
| Investing Cash Flow | $2.21B | +822.1% |
| Financing Cash Flow | -$3.81B | -55.3% |
| Free Cash Flow | $1.96B | -0.7% |
| -28.6% |
| EPS (Basic) | $3.99 | -23.6% |
| EPS (Diluted) | $3.94 | -24.1% |
| Stockholders' Equity |
| $5.16B |
| -19.4% |